Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Executive function and depressive symptoms of retardation in nonelderly stroke patients.

Sobreiro MF, Miotto EC, Terroni L, Tinone G, Iosifescu DV, de Lucia MC, Scaff M, Leite Cda C, Amaro E Jr, Fraguas R.

J Clin Exp Neuropsychol. 2014 Aug;36(6):636-47. doi: 10.1080/13803395.2014.925092.

PMID:
24974834
[PubMed - in process]
2.

Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: Examining the convergence of performance-based measures and self-reports.

Kaye JL, Dunlop BW, Iosifescu DV, Mathew SJ, Kelley ME, Harvey PD.

J Psychiatr Res. 2014 Jun 12. pii: S0022-3956(14)00170-8. doi: 10.1016/j.jpsychires.2014.06.002. [Epub ahead of print]

PMID:
24974001
[PubMed - as supplied by publisher]
3.

Biomarkers in major depressive disorder: the role of mass spectrometry.

Woods AG, Iosifescu DV, Darie CC.

Adv Exp Med Biol. 2014;806:545-60. doi: 10.1007/978-3-319-06068-2_27.

PMID:
24952202
[PubMed - in process]
4.

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.

Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS.

Trials. 2014 Jun 21;15(1):240. doi: 10.1186/1745-6215-15-240.

PMID:
24950747
[PubMed - in process]
Free Article
5.

A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.

Rabideau DJ, Nierenberg AA, Sylvia LG, Friedman ES, Bowden CL, Thase ME, Ketter TA, Ostacher MJ, Reilly-Harrington N, Iosifescu DV, Calabrese JR, Leon AC, Schoenfeld DA.

Clin Trials. 2014 May 28. pii: 1740774514531096. [Epub ahead of print]

PMID:
24872362
[PubMed - as supplied by publisher]
6.

A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder.

Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW.

Biol Psychiatry. 2014 Apr 3. pii: S0006-3223(14)00227-3. doi: 10.1016/j.biopsych.2014.03.026. [Epub ahead of print]

PMID:
24821196
[PubMed - as supplied by publisher]
7.

COGNITIVE-EMOTIONAL TRAINING AS AN INTERVENTION FOR MAJOR DEPRESSIVE DISORDER.

Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS.

Depress Anxiety. 2014 Apr 17. doi: 10.1002/da.22266. [Epub ahead of print]

PMID:
24753225
[PubMed - as supplied by publisher]
8.

Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.

Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, Soleimani L, Charney DS, Foulkes AL, Mathew SJ.

Depress Anxiety. 2014 Apr;31(4):335-43. doi: 10.1002/da.22253. Epub 2014 Mar 25.

PMID:
24668760
[PubMed - in process]
9.

Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder.

O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH.

Biol Psychiatry. 2014 Jan 19. pii: S0006-3223(14)00006-7. doi: 10.1016/j.biopsych.2013.10.028. [Epub ahead of print]

PMID:
24529801
[PubMed - as supplied by publisher]
10.

Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.

Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, Perlis RH.

Bipolar Disord. 2014 Mar;16(2):199-203. doi: 10.1111/bdi.12143. Epub 2013 Dec 27.

PMID:
24372835
[PubMed - in process]
11.

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202. Epub 2013 Oct 3.

PMID:
24117232
[PubMed - in process]
12.

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ.

Int J Neuropsychopharmacol. 2014 Feb;17(2):331-6. doi: 10.1017/S1461145713001119. Epub 2013 Oct 8.

PMID:
24103211
[PubMed - in process]
Free PMC Article
13.

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.

Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE.

Psychopharmacology (Berl). 2013 Sep 11. [Epub ahead of print]

PMID:
24022236
[PubMed - as supplied by publisher]
14.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct 1;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

PMID:
23982301
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH.

J Clin Psychiatry. 2013 Jul;74(7):e636-41. doi: 10.4088/JCP.12m08093.

PMID:
23945458
[PubMed - indexed for MEDLINE]
16.

The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research.

Reilly-Harrington NA, Sylvia LG, Leon AC, Shesler LW, Ketter TA, Bowden CL, Calabrese JR, Friedman ES, Ostacher MJ, Iosifescu DV, Rabideau DJ, Thase ME, Nierenberg AA.

J Psychiatr Res. 2013 Nov;47(11):1686-93. doi: 10.1016/j.jpsychires.2013.07.009. Epub 2013 Jul 30.

PMID:
23911057
[PubMed - indexed for MEDLINE]
17.

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials.

Friedman ES, Calabrese JR, Ketter TA, Leon AC, Thase ME, Bowden CL, Sylvia LG, Ostracher MJ, Severe J, Iosifescu DV, Nierenberg AA, Reilly-Harrington NA.

J Affect Disord. 2014 Jan;152-154:97-104. doi: 10.1016/j.jad.2013.05.052. Epub 2013 Jul 8.

PMID:
23845385
[PubMed - indexed for MEDLINE]
18.

Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).

Beech RD, Leffert JJ, Lin A, Sylvia LG, Umlauf S, Mane S, Zhao H, Bowden C, Calabrese JR, Friedman ES, Ketter TA, Iosifescu DV, Reilly-Harrington NA, Ostacher M, Thase ME, Nierenberg A.

Pharmacogenomics J. 2014 Apr;14(2):182-91. doi: 10.1038/tpj.2013.16. Epub 2013 May 14.

PMID:
23670706
[PubMed - in process]
19.

Tissue-specific differences in brain phosphodiesters in late-life major depression.

Harper DG, Jensen JE, Ravichandran C, Sivrioglu Y, Silveri M, Iosifescu DV, Renshaw PF, Forester BP.

Am J Geriatr Psychiatry. 2014 May;22(5):499-509. doi: 10.1016/j.jagp.2012.08.005. Epub 2013 Jan 11.

PMID:
23567437
[PubMed - in process]
20.

General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.

Kemp DE, Sylvia LG, Calabrese JR, Nierenberg AA, Thase ME, Reilly-Harrington NA, Ostacher MJ, Leon AC, Ketter TA, Friedman ES, Bowden CL, Rabideau DJ, Pencina M, Iosifescu DV; LiTMUS Study Group.

Acta Psychiatr Scand. 2014 Jan;129(1):24-34. doi: 10.1111/acps.12101. Epub 2013 Mar 7.

PMID:
23465084
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk